Carson City hospital foundation receives $10,000 grant

The Carson Tahoe Health Foundation received a $10,000 grant from the Safeway Foundation.

The Carson Tahoe Cancer Center offers free classes on complementary therapies for cancer patients to assist them in coping with the side effects of cancer treatment. In 2015, nearly 1,600 complementary therapy sessions, including yoga, massage, art therapy and other modalities were offered at no cost to cancer patients in order to promote healing and ease the daily life challenges encountered by those undergoing treatment. The Safeway Foundation grant will help underwrite these offerings that greatly improve the quality of life for patients, which cost the Cancer Center over $60,000 a year.

“This generous support funding from the Safeway Foundation will provide hope and healing for hundreds of cancer patients throughout Northern Nevada and

California,” said Kitty McKay, Foundation Director at Carson Tahoe Health. “We are so grateful for their ongoing commitment and support of our community, which totals $150,000 over the years.”

The news of this grant funding comes just a few weeks before Carson Tahoe’s annual HopeFest6, a free outdoor concert with headliners, “The Waybacks”.

All proceeds from food, drink and raffle ticket sales directly benefit local cancer patients, providing support for basic needs that go beyond the hospital walls.

HopeFest6 is from 5-8 p.m. Friday, Aug.19, at the Carson Tahoe Cancer Center, 1535 Medical Parkway.

All proceeds from food, drink and raffle ticket sales directly benefit local cancer patients, providing support for basic needs that go beyond the hospital walls.

Guests interested in attending and supporting can simply show up at the Carson Tahoe Cancer Center and buy food, drinks, raffle tickets, and tribute flags.

For questions about the event, to buy raffle tickets or make a donation in support local cancer patients, please call 775- 445-5166 or email melissa.davis@carsontahoe.org.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment